Axillary Lymph Node Dissection for Inflammatory Breast Cancer

Standard Surgical Approach

The National Comprehensive Cancer Network recommends a complete Level I and II axillary lymph node dissection with at least 10 lymph nodes removed for inflammatory breast cancer patients, and extend to Level III only if gross disease is visible in Level II nodes 1, 2
Level I and II dissection is the recommended staging procedure for all stage III breast cancers, including inflammatory breast cancer, and should include tissue inferior to the axillary vein, extending from the latissimus dorsi muscle laterally to the medial border of the pectoralis minor muscle 1, 2, 4, 5

At least 10 lymph nodes must be examined pathologically to accurately stage the axilla in inflammatory breast cancer patients, representing the established standard for adequate axillary assessment in stage III disease 1, 4

The National Comprehensive Cancer Network recommends extending the dissection to include Level III nodes only if gross disease is apparent in Level II nodes, balancing oncologic adequacy with minimizing surgical morbidity 1, 2, 5

The National Comprehensive Cancer Network suggests that decisions about radiation therapy should be based on pre-chemotherapy tumor characteristics regardless of response, in the context of trimodal therapy with neoadjuvant chemotherapy, surgery, and radiation therapy 5